Extraordinary Circumstances Fund in Roundup Settlement: Who Qualifies

The Extraordinary Circumstances Fund in the Roundup settlement is a supplemental pool of money, capped at 5% of each year’s settlement payments, that pays extra compensation to claimants whose injuries go well beyond what the standard tiered awards cover. Under the proposed $7.25 billion nationwide class settlement announced in February 2026, it is available to people who pursue a full Program Award and can show a qualifying severe circumstance: death before age 78, an organ transplant, or intensive treatment such as CAR-T therapy or intrathecal chemotherapy.¹²

Who Qualifies for an ECF Award

The settlement’s class notice identifies three categories of circumstances that may qualify a claimant for an ECF payment on top of a standard tier award:

Death before age 78
An organ transplant
Specific intensive treatments, including CAR-T therapy and intrathecal chemotherapy

The settlement agreement itself describes the fund as money set aside for these “severe situations.”²¹³ The ECF exists for people whose losses run past that ceiling.

How Much Money Is in the Fund

The ECF is capped at 5% of the annual settlement payment in any given claim year. For the first claim year, that means 5% of the initial payments.² Because the $7.25 billion total is structured as declining capped annual payments over up to 21 years, the actual dollars available in the fund shrink year by year.⁴

Bayer has committed to front-loading $3 billion within the first five years, which is when the ECF pool will be at its largest.³ No public source specifies a maximum dollar amount for any single ECF award. The size of individual payments is left to the claims administrator’s discretion within the annual pool.

Why Quick-Pay Locks You Out of the ECF

This is the decision that matters most for anyone weighing whether they might qualify. Quick-Pay Awards are fixed payments of $6,000 to $14,500 offered to residential claimants and to people diagnosed at age 78 or older. Accepting one closes the door on every other award in the settlement, including the ECF and the separate Extraordinary Residential Exposure Fund.¹

Only claimants who go through the full Program Award process remain eligible to apply for ECF money on top of their tiered payment. If a case involves an organ transplant, CAR-T or intrathecal chemotherapy, or a death before age 78, the fast cash of Quick-Pay comes at the cost of any chance at ECF compensation.

The Extraordinary Residential Exposure Fund Is a Different Pool

The settlement also creates a separate Extraordinary Residential Exposure Fund, funded at 1.5% of each year’s payments, aimed at claimants who used Roundup unusually heavily at home. That fund operates independently from the ECF and fills a different gap: residential users tend to land in lower tiers, and this pool can supplement their awards.² Heavy home use is not, by itself, a qualifying circumstance for the ECF.

What Earlier Roundup Payments Suggest About Timing

An earlier round of Roundup settlements, part of the roughly $11 billion Bayer paid starting in 2020 to resolve about 100,000 individual lawsuits, included a similar mechanism called the Extraordinary Injury Fund. Under that program, approved and appealed EIF claims went to a Special Master whose determinations were final.⁵

The Miller Firm reported in 2023 that initial EIF payments had begun but that the process was slowed by Medicare lien resolution and a required 40% holdback of gross awards pending lien determinations. The firm said at the time it had no estimate for when second EIF payments would be issued, because those depended on the lien administrator.⁵ The takeaway for anyone hoping for an ECF award under the new settlement: supplemental payments of this kind tend to arrive well after standard distributions, and federal healthcare liens can hold them up for a long time.

The Fund Does Not Yet Exist

The entire $7.25 billion settlement, ECF included, depends on final court approval that has not been granted. Missouri Circuit Court Judge Timothy Boyer gave the deal preliminary approval on March 4, 2026, and ordered Bayer to deposit $500 million into a settlement fund within 10 days.⁶ A fairness hearing was scheduled for July 9, 2026, with a June 4, 2026 deadline for class members to opt out or object.⁷

More than 100 class members and a dozen healthcare companies have filed objections, and the case has been through a removal-and-remand fight between Missouri state court and federal court.⁸⁹ As of mid-2026, registration and claim submission through the settlement website are not open.⁷

If the settlement is finalized, current NHL claimants must register within 180 days after final approval and file a claim within 180 days after any appeals are resolved. People exposed before the settlement date but not yet diagnosed would have up to six years after diagnosis, or until the 16th annual payment date, to file.⁷ Anyone considering the ECF should preserve their medical records for organ transplant history, CAR-T or intrathecal chemotherapy treatment, and cause and date of death where relevant, and should hold off on any Quick-Pay election until the full claims process is available for comparison.

1
WeedKillerClass.com. Settlement Class Notice
2
WeedKillerClass.com. Settlement Agreement
3
PR Newswire. Holland Law Firm Announces Monsanto Agreement to Pay Up to $7.25 Billion in Nationwide Settlement
4
Bayer. Monsanto Announces Roundup Class Settlement Agreement
5
The Miller Firm. Roundup Lawsuit
6
The New Lede. Bayer Wins Preliminary Court Approval for Its Proposed Roundup Class Action Settlement
7
WeedKillerClass.com. WeedKillerClass.com
8
Law.com. Federal Roundup Judge Refuses to Step Into Mind-Boggling $7.25B Class Settlement
9
Reuters. Federal Judge Sends Bayer’s $7.25 Billion Roundup Settlement Back to Missouri State Court